The expression of the CCR9 chemokine receptor gene is limited in normal tissues, but the analysis presented here demonstrates that CCR9 is over-expressed in >80% of T-ALL leukemia patients, and in a considerable fraction of other hematopoietic and non-hematopoietic tumors. This evidence concerns the gene CCR9 and leukemia.